Update on Medtronic’s HeartWare Ventricular Assist Device System

The FDA is providing updated information on Medtronic's HeartWare Ventricular Assist Device (HVAD) system.

If your email program has trouble displaying this email, view as a webpage. The FDA is providing updated information on Medtronic's HeartWare Ventricular Assist Device (HVAD) system. Today, the U.S. Food and Drug Administration (FDA) is providing updates to the FDA website to include information on recent recalls conducted by Medtronic. These recalls include information on battery performance issues as well as the availability of a modified software for select patients. The FDA remains committed to providing updates about the safety profile of the HeartWare Ventricular Assist Device (HVAD) System. Read More Questions? If you have questions about the Medtronic HeartWare Ventricular Assist Device (HVAD) System, contact the Division of Industry and Consumer Education.

Follow us on Twitter at @FDADeviceInfo Manage Subscriptions  |  Unsubscribe All  |  Help

This email was sent to ooseims.archieves@blogger.com using GovDelivery Communications Cloud on behalf of: U.S. Food and Drug Administration ·  10903 New Hampshire Ave · Silver Spring, MD ·  20993-0002 ·  1-888-INFO-FDA